Weekly Analysts’ Ratings Changes for Ventas (VTR)

Ventas (NYSE: VTR) recently received a number of ratings updates from brokerages and research firms:

• 1/9/2026 – Ventas is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $94.00 price target on the stock.
• 1/9/2026 – Ventas is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $94.00 price target on the stock.
• 1/5/2026 – Ventas had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $93.00 price target on the stock.
• 12/29/2025 – Ventas was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 12/22/2025 – Ventas had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Ventas had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $93.00 price target on the stock.
• 12/15/2025 – Ventas was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating.
• 12/8/2025 – Ventas had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/4/2025 – Ventas had its price target raised by analysts at KeyCorp from $70.00 to $85.00. They now have an “overweight” rating on the stock.
• 12/1/2025 – Ventas had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Ventas was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 11/25/2025 – Ventas had its price target raised by analysts at Wells Fargo & Company from $80.00 to $88.00. They now have an “overweight” rating on the stock.
• 11/19/2025 – Ventas had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.

Ventas Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be given a $0.48 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio is presently 369.23%.

Insider Transactions at Ventas

In other news, CFO Robert F. Probst sold 29,930 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the sale, the chief financial officer owned 138,434 shares in the company, valued at $10,694,026.50. The trade was a 17.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Peter J. Bulgarelli sold 2,229 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $80.08, for a total value of $178,498.32. Following the completion of the transaction, the chief executive officer directly owned 106,488 shares in the company, valued at $8,527,559.04. The trade was a 2.05% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 713,520 shares of company stock worth $52,788,577. 0.80% of the stock is owned by insiders.

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.